Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 477

Results For "Patient"

5068 News Found

Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027
News | September 28, 2021

Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027

One of the key factors driving the market growth is the rise in the occurrence of chronic cardiovascular diseases such as heart failure and coronary artery disease: Valuates Reports


Tavneos (avacopan) approved for ANCA associated vasculitis in Japan
Drug Approval | September 28, 2021

Tavneos (avacopan) approved for ANCA associated vasculitis in Japan

It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan


Larsen & Toubro Infotech partners with eClinicalHealth to accelerate clinical research
Healthcare | September 28, 2021

Larsen & Toubro Infotech partners with eClinicalHealth to accelerate clinical research

As part of this strategic partnership, LTI with its digital, technical and life sciences domain capabilities, will help accelerate joint go-to-market pursuits and faster deployment for Clinpal Adopters


Sun Pharma launches novel cough medicine
Drug Approval | September 28, 2021

Sun Pharma launches novel cough medicine

Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug


PM Modi launches Ayushman Bharat Digital Mission
Public Health | September 27, 2021

PM Modi launches Ayushman Bharat Digital Mission

The Mission will simplify hospital processes and will increase Ease of Living. Under this, every citizen will get a digital health ID and their health record will be digitally protected.


QMS Medical partners with ZEISS for screening diabetic retinopathy
Medical Device | September 27, 2021

QMS Medical partners with ZEISS for screening diabetic retinopathy

Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes


SAB Biotherapeutics’ SAB-185 moves to Phase 3 trial for Covid-19 treatment
Biotech | September 26, 2021

SAB Biotherapeutics’ SAB-185 moves to Phase 3 trial for Covid-19 treatment

Advancement to Phase 3 is a major milestone for SAB’s unique DiversitAb immunotherapy platform that produces fully human polyclonal antibodies without human donors


MedleyMed enters the U.S. market with a suite of digital health solutions
Digitisation | September 26, 2021

MedleyMed enters the U.S. market with a suite of digital health solutions

The company plans to launch its exclusive e-pharmacy and telemedicine services in India by December 2021


AstraZeneca Pharma India receives permission for paediatric drug
Drug Approval | September 26, 2021

AstraZeneca Pharma India receives permission for paediatric drug

It paves way for the launch of Selumetinib 10 mg & 25 mg capsule in India, subject to the receipt of related statutory approvals and licenses


Zydus Cadila receives final approval for Apremilast
Drug Approval | September 24, 2021

Zydus Cadila receives final approval for Apremilast

Zydus' Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy